The Effect of Counseling Based on the Roy Adaptation Model on Sexual Life and Quality of Life in Menopause

What this trial studies

In this study, it was aimed to determine the effect of the support and counseling program based on the Roy Adaptation Model given to postmenopausal women with Genitourinary Syndrome on their sexual life and quality of life.

Conditions in scope

• Genitourinary Syndrome of Menopause
• Female
• Postmenopause

Interventions

• Consultancy (Other) — In the single-blind method, subjects do not know which of the experimental or control groups they were selected and therefore which method was applied to them.The researcher knows the subjects selected for the experimental and control groups, and therefore which…

Who can join

Women only · Ages 40 Years to 60 Years · Accepts healthy volunteers.

Inclusion criteria

• Those between the ages of 40-60
• Verbal communication established
• Having an active sex life
• No menstruation for at least 1 year
• It has been determined that she has entered menopause with the hormone value in the blood (FSH above 25).
• Women who agree to participate in the study will be included in the sample group.

Exclusion criteria

• Those with advanced prolapse
• Those with Urinary Incontinence
• Those with systemic HRT
• Those who have neurological or psychiatric disorders, use antidepressants and derivatives
• Women who do not agree to participate in the research will be excluded from the study.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2021-11-01
• Primary completion: 2022-05-06
• Last update posted: 2024-09-20
• First posted: 2024-09-20

Sponsor & contact

Lead sponsor: Istanbul University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Sexual functions (5 months)
  FSFI (Female Sexual Function Index) was used to evaluate sexual function. FSFI is a 19-item scale developed by Rosen et al. (2000) to evaluate female sexual function. Turkish validity and reliability study was conducted by Öksüz and Malhan in 2005. FSFI evaluates sexual function or problems involving the last four weeks. A minimum raw score of 4 and a maximum…
• The quality of life of postmenopausal women (5 months)
  The Menopause Specific Quality of Life Questionnaire- MENQOL was used to assess quality of life. MENQOL is a self-administered tool developed by Hilditch et al. (1996) to assess the quality of life of menopausal women. The Turkish validity and reliability study of the scale was conducted by Kharbouch and Şahin. In MENQOL, each question item is scored between 1-8 points.…
• Vaginal symptoms (5 months)
  The International Consultation on Incontinence Questionnare-Vaginal Symptoms (ICIQVS) was used to evaluate vaginal symptoms. The ICIQ-VS scale was developed by Price et al. in 2006. Turkish validity and reliability study was conducted by Rüstemoğlu and Aslan (2021). The ICIQ-VS scale consists of 14 questions, 25 items with sub-questions, and 3 sub-dimensions (vaginal symptoms, sexual issues and quality of life).
• Depression (5 months)
  Beck Depression Scale was used to evaluate depression. It was developed by Beck et al. The Turkish validity and reliability study was conducted by Hisli in 1989. The BDI consists of 21 items assessing the severity of depression. The total score for the whole scale ranges from 0 to 63 points. The degree of depression is indicated by the total…

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.